BMS, Pfizer turned away from SCOTUS in high-profile cases
09 Jan 2023 //
FIERCE PHARMA
Gilead hits back at Bristol Myers` Supreme Court petition in CAR-T patent feud
26 Aug 2022 //
FIERCEPHARMA
Oxford Biomedica expands Agreement with Juno Therapeutics
21 Jul 2022 //
OXB
BMS takes CAR-T patent case to US top court after appeals loss
17 Jun 2022 //
FIERCEPHARMA
Indapta snags $50M and signs on former Juno exec as CEO
10 Feb 2022 //
FIERCEBIOTECH
Juno, WuXi JV wins China nod for Breyanzi sister CAR-T
03 Sep 2021 //
FIERCEPHARMA
JW`s relma-cel lands second-ever CAR-T approval in China
03 Sep 2021 //
ENDPTS
With $588M IPO, Sana leads wave of new biotechs going public
04 Feb 2021 //
BIOPHARMADIVE
JW Therapeutics hauls in $300M IPO just as liso-cel-inspired CAR-T
04 Nov 2020 //
ENDPTS
Kite Pharma Wants Fed. Circ. To Nix Juno`s $1.2B Patent Win
02 Sep 2020 //
LAW360
Teamed up with Lyell, Juno/WuXi joint venture files IPO betting on China`s CAR-T
17 Aug 2020 //
ENDPTS
Juno joint venture seeks IPO haul to bring CAR-Ts to China
17 Aug 2020 //
FIERCEBIOTECH
Juno/WuXi`s cell therapy venture buys out solid tumor player in China, gaining
21 Jul 2020 //
ENDPTS